Predicting Oncotype DX scores using clinicopathologic features: A report from the National Cancer Database.

被引：2
|
作者：
Pesce, Catherine
Kuchta, Kristine
Erdogan, Beyza
Wang, Chihsiung
Yao, Katharine
El-Tamer, Mahmoud
机构：
[1] NorthShore Univ Hlth Syst, Dept Surg, Evanston, IL USA
[2] NorthShore Univ Hlth Syst, Evanston, IL USA
[3] NorthShore Univ HealthSyst, Evanston, IL USA
[4] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
551
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Identifying Factors Associated with Slow Adoption of Oncotype DX Utilization: Analysis Using the National Cancer Data Base
    McGreevy, C.
    Williams, A. D.
    Nazarian, S. M.
    Anderson, D.
    De La Cruz, L.
    Tchou, J.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S105 - S105
  • [32] Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis
    Roy, Arya Mariam
    Jiang, Changchuan
    Perimbeti, Stuthi
    Deng, Lei
    Shapiro, Charles L.
    Gandhi, Shipra
    CANCERS, 2023, 15 (17)
  • [33] READY FOR THE NATIONAL ACCREDITATION OF PROGRAMS FOR RECTAL CANCER? AN AUDIT OF RECTAL CANCER OUTCOMES IN THE UNITED STATES FROM THE NATIONAL CANCER DATABASE.
    de Paula, T. Reif
    Keller, D. S.
    Kiran, R. P.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : E366 - E367
  • [34] The prediction of Oncotype DX risk group using clinicopathologic factors in patients with HR+/HER2-early breast cancer
    Song, R.
    Lee, D. -E.
    Lee, S.
    Kang, H. -S.
    Han, J. H.
    Lee, K. S.
    Sim, S. H.
    Chae, H.
    Kwon, Y.
    Woo, J.
    Lee, M.
    Lee, E. -G.
    Jung, S. -Y.
    BREAST, 2023, 68 : S74 - S75
  • [35] HER2-Low/Estrogen Receptor-Positive Early-Stage Breast Carcinomas: Association with Clinicopathologic Features, Oncotype DX Recurrence Scores and HER2 RNA Expression Scores
    Hu, Yan
    Jones, Dan
    Zhao, Weiqiang
    Parwani, Anil
    Li, Zaibo
    LABORATORY INVESTIGATION, 2023, 103 (03) : S146 - S147
  • [36] Clinicopathologic features and radiation therapy utilization in patients with male breast cancer: A national cancer database (NCDB) study
    Algan, O.
    Herman, T.
    CANCER RESEARCH, 2016, 76
  • [37] Associations between the 21-gene Oncotype DX Recurrence Score (RS), Ki67, and Race in Early Breast Cancer (EBC) Using the National Cancer Database (NCDB)
    Patel, Rima
    Kwon, Deukwoo
    Van Hyfte, Grace
    Sparano, Joseph
    Tiersten, Amy
    CANCER RESEARCH, 2023, 83 (05)
  • [38] Can Oncotype DX Testing Be Omitted in Invasive Breast Cancer Patients with Clinicopathologic Factors Predicting Very High Pre-test Probability of a Concordant Result?
    Kapadia, Sonam
    Gudiwada, Sai Priyanka
    Kaji, Amy
    Chlebowski, Rowan
    Venegas, Rose
    Ozao-Choy, Junko
    Dauphine, Christine
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S560 - S561
  • [39] The epidemiology of metaplastic breast cancer: A review of 2,500 cases from the national cancer database.
    Campbell, Brittany Morgan
    Thomas, Samantha Marie
    Ong, Cecilia Tuongquang
    Greenup, Rachel Adams
    Plichta, Jennifer Kay
    Rosenberger, Laura Horst
    Force, Jeremy Meyer
    Hyslop, Terry
    Hwang, Eun-Sil Shelley
    Fayanju, Oluwadamilola Motunrayo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Does Clinicopathologic Features Influence the Use of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients Who Have an Oncotype DX Intermediate Risk Score?
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    MODERN PATHOLOGY, 2013, 26 : 59A - 59A
12345